Sign In
Buy NVO
$47.41
-0.0100 (-0.0211%)
At Close: Jun 24, 2026
Explainer: What Novo Nordisk's weight-loss pill approval means for company, patients
07:08am, Tuesday, 23'rd Dec 2025
The U.S. Food and Drug Administration's approval of an oral version of Novo Nordisk's weight-loss drug Wegovy could potentially expand access to millions of patients and give the Danish company a much
Eli Lilly Stock Falls. Novo Nordisk Got a Wegovy Weight-Loss Pill Approved in U.S.
06:30am, Tuesday, 23'rd Dec 2025
Novo said it expects to launch the weight-loss pill in the U.S. in early January.
Wall Street Breakfast Podcast: Wegovy Without The Needle Sparks Novo Surge
06:29am, Tuesday, 23'rd Dec 2025
Novo Nordisk (NVO) surges ~7% premarket as FDA approves the first oral GLP-1 obesity therapy, Wegovy pill, launching January 2026. ByteDance (BDNCE) targets ~$23B capex for 2026, prioritizing AI infra
Novo Nordisk surges as US approves first weight-loss pill
06:16am, Tuesday, 23'rd Dec 2025
Novo Nordisk (NYSE:NVO) shares rose nearly 8% after the US Food and Drug Administration approved its Wegovy pill, the first oral GLP-1 treatment for weight management. Currently, GLP-1 treatments f
Novo Nordisk surges as US approves first weight-loss pill
06:05am, Tuesday, 23'rd Dec 2025
Novo Nordisk (NYSE:NVO) shares rose nearly 8% after the US Food and Drug Administration approved its Wegovy pill, the first oral GLP-1 treatment for weight...
Why Novo Nordisk stock is rocketing
05:41am, Tuesday, 23'rd Dec 2025
Novo Nordisk (NYSE: NVO) shares surged in pre-market and after-hours trading after the company secured U.S. regulatory approval for the world's first GLP-1 weight-loss pill, a milestone that materiall
Novo Nordisk first out of the gate with oral weight-loss drug, and its stock jumps
05:18am, Tuesday, 23'rd Dec 2025
Relief rally underway in Novo Nordisk after a difficult year for the stock which saw it lose ground to arch-competitor Eli Lilly.
Novo Nordisk Shares Jump After FDA Approves Pill Version of Wegovy
05:05am, Tuesday, 23'rd Dec 2025
The approval gives Novo Nordisk a chance to regain ground lost to rival Eli Lilly.
Novo Nordisk Shares Surge 7% In Tuesday Pre-Market After US FDA Approves Wegovy Pill
04:30am, Tuesday, 23'rd Dec 2025
U.S.-listed shares of Novo Nordisk A/S soared 7.36% during Tuesday's pre-market session following the approval of its GLP-1 pill by the U.S. FDA.
Shares in Wegovy-maker Novo Nordisk pop 6% after GLP-1 pill approval
03:02am, Tuesday, 23'rd Dec 2025
The FDA on Monday approved the first-ever GLP-1 pill from Novo Nordisk. The approval gives the Danish pharma giant a head start against U.S. rival Eli Lilly.
Novo Nordisk up nearly 10% in Frankfurt after US approves weight loss pill
02:18am, Tuesday, 23'rd Dec 2025
Novo Nordisk's Frankfurt-listed shares opened nearly 10% higher in early trading on Tuesday after the U.S. Food and Drug Administration approved its weight-loss pill.
Novo Gets Approval to Sell Wegovy Obesity Pill in the US
01:57am, Tuesday, 23'rd Dec 2025
Novo Nordisk A/S won approval to sell a pill version of its obesity shot Wegovy in the US. Novo will start selling the pill, the first of the blockbuster GLP-1 class, in the US in early January.
Novo's Wegovy pill to test demand from consumers with cash
01:06am, Tuesday, 23'rd Dec 2025
Novo Nordisk's newly approved weight-loss pill version of Wegovy will be a test case for the fast-growing cash-paying consumer market, with plans for the first highly effective oral treatment to go st
Novo Nordisk Jumps As FDA OKs Wegovy Pill As First-Ever Oral GLP-1 Weight Loss Drug
06:44pm, Monday, 22'nd Dec 2025
The FDA approved Novo Nordisk's Wegovy pill as the first oral GLP-1 treatment for weight loss. The Danish drug giant jumped overnight.
FDA approves first GLP-1 pill for obesity from Novo Nordisk
06:09pm, Monday, 22'nd Dec 2025
FDA approves first GLP-1 pill for obesity from Novo Nordisk
